 Gregory Kobak
Concepts (74)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrostomy | 2 | 2018 | 130 | 0.260 |
Why?
| | Hepatocytes | 2 | 2005 | 221 | 0.260 |
Why?
| | Bile Acids and Salts | 2 | 2005 | 164 | 0.250 |
Why?
| | Hepatitis B, Chronic | 1 | 2004 | 22 | 0.210 |
Why?
| | Interferon-alpha | 1 | 2004 | 197 | 0.200 |
Why?
| | Fatty Liver | 1 | 2005 | 251 | 0.180 |
Why?
| | Gastric Fistula | 1 | 2000 | 9 | 0.160 |
Why?
| | Cutaneous Fistula | 1 | 2000 | 14 | 0.160 |
Why?
| | Device Removal | 1 | 2000 | 142 | 0.140 |
Why?
| | Abdominal Wall | 1 | 2018 | 27 | 0.140 |
Why?
| | Antiviral Agents | 1 | 2004 | 767 | 0.140 |
Why?
| | Intubation, Gastrointestinal | 1 | 2018 | 82 | 0.130 |
Why?
| | Enteral Nutrition | 1 | 2000 | 216 | 0.130 |
Why?
| | Virtual Reality | 1 | 2019 | 76 | 0.130 |
Why?
| | Esophagoscopy | 1 | 2019 | 221 | 0.130 |
Why?
| | Mitochondria, Liver | 2 | 2005 | 70 | 0.110 |
Why?
| | Models, Theoretical | 1 | 2018 | 582 | 0.110 |
Why?
| | Eosinophilic Esophagitis | 1 | 2019 | 330 | 0.110 |
Why?
| | Ultrasonography | 1 | 2018 | 768 | 0.110 |
Why?
| | Hepatitis, Autoimmune | 1 | 2012 | 13 | 0.090 |
Why?
| | Giant Cells | 1 | 2012 | 21 | 0.090 |
Why?
| | Purpura, Thrombocytopenic, Idiopathic | 1 | 2012 | 17 | 0.090 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2012 | 97 | 0.090 |
Why?
| | Reactive Oxygen Species | 2 | 2005 | 621 | 0.090 |
Why?
| | Liver Failure | 1 | 2012 | 83 | 0.090 |
Why?
| | Immunologic Factors | 1 | 2012 | 255 | 0.080 |
Why?
| | Nutritional Status | 2 | 2018 | 354 | 0.080 |
Why?
| | Glycochenodeoxycholic Acid | 2 | 2005 | 14 | 0.070 |
Why?
| | Cytochromes c | 2 | 2005 | 53 | 0.070 |
Why?
| | Postoperative Complications | 1 | 2000 | 2916 | 0.060 |
Why?
| | Rats, Zucker | 1 | 2005 | 32 | 0.060 |
Why?
| | Child, Preschool | 4 | 2019 | 11774 | 0.060 |
Why?
| | Infant | 4 | 2018 | 10022 | 0.060 |
Why?
| | Cell Membrane Permeability | 1 | 2005 | 85 | 0.060 |
Why?
| | Caspase Inhibitors | 1 | 2005 | 81 | 0.050 |
Why?
| | Antioxidants | 2 | 2005 | 549 | 0.050 |
Why?
| | Liver Function Tests | 1 | 2004 | 106 | 0.050 |
Why?
| | Necrosis | 1 | 2005 | 244 | 0.050 |
Why?
| | Adenosine Triphosphate | 1 | 2005 | 498 | 0.050 |
Why?
| | Enzyme Inhibitors | 1 | 2005 | 824 | 0.040 |
Why?
| | Recombinant Proteins | 1 | 2004 | 1367 | 0.040 |
Why?
| | Apoptosis | 2 | 2005 | 2430 | 0.040 |
Why?
| | Survival Rate | 1 | 2004 | 2088 | 0.040 |
Why?
| | Medical Records | 1 | 2000 | 186 | 0.040 |
Why?
| | Retrospective Studies | 3 | 2019 | 17009 | 0.040 |
Why?
| | Male | 6 | 2019 | 72035 | 0.040 |
Why?
| | Replantation | 1 | 2018 | 32 | 0.040 |
Why?
| | Endoscopy, Digestive System | 1 | 2019 | 140 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2018 | 6424 | 0.030 |
Why?
| | Wound Healing | 1 | 2000 | 351 | 0.030 |
Why?
| | Adolescent | 3 | 2019 | 22281 | 0.030 |
Why?
| | Esophagus | 1 | 2019 | 261 | 0.030 |
Why?
| | Child | 3 | 2019 | 22537 | 0.030 |
Why?
| | Rats | 1 | 2005 | 5592 | 0.030 |
Why?
| | Biopsy | 1 | 2019 | 1075 | 0.030 |
Why?
| | Disease Management | 1 | 2019 | 643 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2005 | 4556 | 0.030 |
Why?
| | Female | 4 | 2019 | 77976 | 0.020 |
Why?
| | Young Adult | 2 | 2019 | 13990 | 0.020 |
Why?
| | Obesity | 1 | 2005 | 3057 | 0.020 |
Why?
| | Rituximab | 1 | 2012 | 209 | 0.020 |
Why?
| | Humans | 6 | 2019 | 144261 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 4278 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2004 | 11643 | 0.020 |
Why?
| | Time Factors | 1 | 2019 | 7155 | 0.020 |
Why?
| | Taurochenodeoxycholic Acid | 1 | 2005 | 8 | 0.010 |
Why?
| | Spectrophotometry | 1 | 2005 | 60 | 0.010 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2005 | 46 | 0.010 |
Why?
| | Ion Channels | 1 | 2005 | 129 | 0.010 |
Why?
| | Cyclosporine | 1 | 2005 | 265 | 0.010 |
Why?
| | Hydrogen Peroxide | 1 | 2005 | 336 | 0.010 |
Why?
| | Animals | 1 | 2005 | 38030 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 2026 | 0.010 |
Why?
| | Adult | 1 | 2018 | 40262 | 0.010 |
Why?
|
|
Kobak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|